TP53 harbored 36 mutations from 31 samples (24 variants from 21 CRC samples, 7 from 5 CP samples, and 5 from 5 IBD) and APC harbored 30 mutations from 26 samples (16 variants from 14 CRC samples, 10 from 9 CP, and 4 from 3 IBD). This evidence concerns the gene TP53 and colorectal carcinoma.